Oral isotretinoin and pregnancy prevention programmes
Authors:
- D. ThiboutotDTD. Thiboutot
- for theGlobalAlliance toImproveOutcomes inAcneFIfor theGlobalAlliance toImproveOutcomes inAcne
- 10 October 2011
- journal article
- other
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 166 (2) , 466-467
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care systemJournal of the American Academy of Dermatology, 2011
- Isotretinoin and iPledge: A view of resultsJournal of the American Academy of Dermatology, 2011
- Drug safety in pregnancy: Utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information ServicesCongenital Anomalies, 2011
- Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic reviewBritish Journal of Dermatology, 2011
- The individual health burden of acneJournal of Health Psychology, 2009
- The prevalence of acne in adults 20 years and olderJournal of the American Academy of Dermatology, 2008
- Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity™ (SMART™) risk management programPharmacoepidemiology and Drug Safety, 2005
- Beliefs, perceptions and psychological impact of Acne vulgaris among patients in the Assir region of Saudi ArabiaWest Africa Journal of Medicine, 2004
- The psychosocial impact of acne: Patients' perceptionsJournal of the American Academy of Dermatology, 1995
- Prevalence of facial acne vulgaris in late adolescence and in adults.BMJ, 1979